H. Çamlıca Et Al. , "Leptin and BCL-2 in addition to CA 12-5: Is it a sensitive and accurate way of diagnosis?," 31st Congress of the European-Society-for-Medical-Oncology , vol.17, İstanbul, Turkey, pp.65, 2006
Çamlıca, H. Et Al. 2006. Leptin and BCL-2 in addition to CA 12-5: Is it a sensitive and accurate way of diagnosis?. 31st Congress of the European-Society-for-Medical-Oncology , (İstanbul, Turkey), 65.
Çamlıca, H., OĞUZ, H., Disci, R., Topuz, E., & Yasasever, V., (2006). Leptin and BCL-2 in addition to CA 12-5: Is it a sensitive and accurate way of diagnosis? . 31st Congress of the European-Society-for-Medical-Oncology (pp.65). İstanbul, Turkey
Çamlıca, Hakan Et Al. "Leptin and BCL-2 in addition to CA 12-5: Is it a sensitive and accurate way of diagnosis?," 31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 2006
Çamlıca, Hakan Et Al. "Leptin and BCL-2 in addition to CA 12-5: Is it a sensitive and accurate way of diagnosis?." 31st Congress of the European-Society-for-Medical-Oncology , İstanbul, Turkey, pp.65, 2006
Çamlıca, H. Et Al. (2006) . "Leptin and BCL-2 in addition to CA 12-5: Is it a sensitive and accurate way of diagnosis?." 31st Congress of the European-Society-for-Medical-Oncology , İstanbul, Turkey, p.65.
@conferencepaper{conferencepaper, author={Hakan ÇAMLICA Et Al. }, title={Leptin and BCL-2 in addition to CA 12-5: Is it a sensitive and accurate way of diagnosis?}, congress name={31st Congress of the European-Society-for-Medical-Oncology}, city={İstanbul}, country={Turkey}, year={2006}, pages={65} }